“…Most ongoing clinical trials concern treatments of various cancers caused by solid tumors. In general, nanomedicines are developed as drug delivery systems, but several projects concern nanomaterials to be used in cancer radiotherapy [Hainfeld et al, 2014, Mi et al, 2016, Lacombe et al, 2017, Lamch et al, 2018. Beside treating cancers and infections, nanomedicines hold promise to improve the life of patients suffering from brain diseases [Andrieux and Couvreur, 2013, Kreuter, 2014, Savaira et al, 2016, Zhou et al, 2018, cardiovascular diseases [Ferreira et al, 2015, Suarez et al, 2015, Varna et al, 2015, Chan et al, 2018, Cicha et al, 2018, Dormont et al, 2018 and metabolic diseases [Pridgen et al, 2015, Aguirre et al, 2016, Wong et al, 2017.…”